test

Harold Schaaff

@Soleus Capital Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
XBISpdr Ser Tr
Recent Activity
New Position
6.89%
$88.92M↑ Call
900,000 shares@ $98.8 avg price
GRFSGrifols S A
Recent Activity
New Position
3.11%
$40.153M
4.522M shares@ $8.89 avg price
QDELQuidelortho Corp
Recent Activity
New Position
2.43%
$31.282M
686,000 shares@ $45.6 avg price
LLYEli Lilly & Co
Recent Activity
New Position
1.33%
$17.099M
19,300 shares@ $885.94 avg price
ANIPAni Pharmaceuticals Inc
Recent Activity
New Position
1.25%
$16.049M
269,000 shares@ $59.66 avg price
ELVElevance Health Inc
Recent Activity
New Position
1.2%
$15.418M
29,650 shares@ $520.0 avg price
LBPHLongboard Pharmaceuticals In
Recent Activity
New Position
0.83%
$10.608M
318,269 shares@ $33.34 avg price
TAKTakeda Pharmaceutical Co Ltd
Recent Activity
New Position
0.56%
$7.11M
500,000 shares@ $14.22 avg price
RLAYRelay Therapeutics Inc
Recent Activity
New Position
0.5%
$6.443M
910,000 shares@ $7.08 avg price
SMMTSummit Therapeutics Inc
Recent Activity
New Position
0.49%
$6.242M
285,000 shares@ $21.9 avg price